GRFS
Grifols SA ADR
NASDAQ: GRFS · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$7.91
-1.98% today
Updated 2026-04-29
Market cap
$5.38B
P/E ratio
11.46
P/S ratio
0.72x
EPS (TTM)
$0.69
Dividend yield
2.22%
52W range
$7 – $11
Volume
0.8M
Grifols SA ADR (GRFS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $49.08M | $88.64M | $73.41M | $88.18M | $104.25M | $220.23M | $507.12M | $592.01M | $978.93M | $742.78M | $553.28M | $841.75M | $737.43M | $568.93M | $1.11B | $596.98M | $-10.87M | $218.69M | $902.17M | $1.01B |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $118.77M | $103.40M | $159.90M | $166.13M | $172.85M | $287.04M | $567.02M | $292.69M | $322.97M | $307.72M | $412.31M | $362.56M | $315.09M | $375.56M | $310.32M | $371.37M | $254.54M |
| Depreciation | $29.36M | $31.53M | $33.26M | $39.55M | $45.78M | $90.64M | $129.13M | $128.47M | $189.47M | $189.75M | $201.87M | $215.49M | $228.61M | $302.45M | $321.53M | $359.77M | $407.86M | $446.42M | $437.90M | — |
| Stock-based comp | $-45.92M | $-43.97M | $-70.51M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Free cash flow | $49.08M | $88.64M | $73.41M | $-30.59M | $850000.00 | $60.33M | $340.99M | $419.16M | $691.89M | $175.76M | $260.59M | $518.77M | $429.71M | $156.63M | $747.78M | $281.89M | $-386.43M | $-91.63M | $530.80M | $751.14M |
| Investing cash flow | $-95.29M | $-70.71M | $-130.77M | $-135.95M | $-104.06M | $-1.62B | $-64.44M | $-236.03M | $-1.52B | $-633.11M | $-506.65M | $-2.19B | $-781.87M | $-548.79M | $-858.12M | $-29.39M | $-1.98B | $-394.72M | $886.67M | — |
| Financing cash flow | $50.41M | $-38.13M | $58.38M | $290.90M | $-29.27M | $1.47B | $-305.33M | $-105.15M | $841.12M | $-158.04M | $-329.56M | $1.43B | $152.50M | $-332.36M | $-354.40M | $1.47B | $-173.49M | $171.49M | $-1.36B | — |
| Dividends paid | $7.00M | $12.80M | $34.79M | $80.91M | $27.28M | — | $281.30M | $69.14M | $156.01M | $221.77M | $216.15M | $218.26M | $278.84M | $238.74M | $113.23M | $258.95M | $592000.00 | $0.00 | $962000.00 | $122.95M |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — |